P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects

• Curtis Gravance,
• Drago Bratkovic,
• David Ketteridge,
• Michael Imperiale,
• Ravi Krishnan,
• Divya Navuru

Affiliations

Curtis Gravance

Paradigm Biopharmaceuticals Ltd

Drago Bratkovic

Women’s and Children’s Hospital, South Australia

David Ketteridge

Women’s and Children’s Hospital, South Australia

Michael Imperiale

Paradigm Biopharmaceuticals Ltd

Ravi Krishnan

Paradigm Biopharmaceuticals Ltd

Divya Navuru

Paradigm Biopharmaceuticals Ltd